Gastrointestinal hormones inthe blood serum of patients with chronic renal failure
- Authors: Dzhavad-Zade MD1, Karaev ME1
-
Affiliations:
- Issue: No 5 (2004)
- Pages: 56-58
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/275596
- ID: 275596
Cite item
Full Text
Abstract
Content of gastrointestinal hormones (gastrin, insulin, glucagon,
C-peptide), (^-microglobulin, glomerular filtration rate (GFR) were
studied in 65 patients with nephrolithiasis (NL) and in 73 patients
with chronic renal failure (CRF). It was found that NL with GFR
under 80 ml/min runs with elevated insulin, glucagon and C-peptide
while CRF with CRF under 30 ml/min is characterized by aggravated
disorders of hormonal homeostasis (gastrin, insulin, glucagons, C-peptide
elevation). As gastrointestinal hormones in patients with CRF
are high, it is recommended to combine medication with diet containing
low amount of carbohydrates easy for digestion which is important
in the treatment of CRF.
C-peptide), (^-microglobulin, glomerular filtration rate (GFR) were
studied in 65 patients with nephrolithiasis (NL) and in 73 patients
with chronic renal failure (CRF). It was found that NL with GFR
under 80 ml/min runs with elevated insulin, glucagon and C-peptide
while CRF with CRF under 30 ml/min is characterized by aggravated
disorders of hormonal homeostasis (gastrin, insulin, glucagons, C-peptide
elevation). As gastrointestinal hormones in patients with CRF
are high, it is recommended to combine medication with diet containing
low amount of carbohydrates easy for digestion which is important
in the treatment of CRF.
References
- Джавад-Заде М. Д., Мальков П. С. Хроническая почечная недостаточность. М.: Медицина; 1978.
- Кэттайл В. М., Арки Р. А. Патофизиология эндокринной системы: Пер. с англ. М.; 2001.
- Лопаткин Н. А. Руководство по урологии. М.: Медицина; 1998; т. 3.
- Ciccotosto G. D., Dawborn J. К., Hardy К. J., Shulkes A. Gastrin processing and secretion in patients with end-stage renal failure.J. Clin. Endocrinol. Metab. 1996; 81 (9): 3231-3238.
- Muto S., Nurazama N., Asano Y. et al. Hypergastrinemia and achlorhydria in chronic renal failure. Nephron 1985; 40: 143- 148.
- Джавад-Заде М. Д., Агаев М. М., Караев М. Э. Паратирин и кальцитонин у больных хронической почечной недостаточностью. Мед. радиол. 1985; 12: 47-49.
- Трусов В. В., Казакова И. А. Особенности нарушения секреции инсулина и С-пептида у больных с хроническим гломерулонефритом. Урол. и нефрол. 1987; 4: 57-61.
- KangJ. Y. Peptic ulcer in hepatic cirrhosis and renal failure. J. Gastroenterol. Hepatol. 1994; 9 (suppl. 1): S20-S23.
- Джавад-Заде С. М. Мочекаменная болезнь в эндемическом регионе. Баку: Воен. изд-во; 1996.
- Ravelli A. M. Gastrointestinal function in chronic renal failure. Pediatr. Nephrol. 1995; 9 (6): 756-762.
- Dagogo-Jack S., Franklin S. C., Vijayan A. et al. Recombinant human insulin-like growth factor-I (ICF-I) therapy decreases plasma Ieptin concentration in patients with chronic renal insufficiency. Int. J. Obes. Relat. Metab. Disord. 1998; 22 (11): 1110-1115.
- Лацыбина В. В., Баран Е. Я. Клиническое значение определения р2-микроглобулина при заболеваниях почек. Уролю и нефрол. 1984; 3: 53-56.
- Escalada J., Teruel J. L., Pavon I. et al. Normal calcitonin response to pentagastrin stimulation in patients with chronic renal failure. Acta Endocrinol. (Kbh.). 1993; 129 (1): 39-41.
- Franceschini R., Robaudo C., Corsini G. et al. Somatostatin release in response to glucose is impaired in chronic renal failure. Biomed. Pharmacother. 1998; 52 (5): 208-213.
- Lu F., Li P., Zheng F. et al. Serum insulin-like growth factor 1 level and nutritional assessment in nondialytic patients with chronic renal failure. Kidney Blood Press. Res. 2002; 25 (2): 116-119.
- Eidemak I., Feldt-Rasmussen В., Kanstrup I. L. et al. Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 1995; 38 (5): 565-572.
- Feneberg R., Sparber M., Veldhuis J. D. e al. Altered temporal organization of plasma insulin oscillations in chronic renal failure. J. Clin. Endocrinol. Metab. 2002; 87 (5): 1965-1973.
- Fiorini F., Raffa M., Patrone E., Castelluccio A. Glucose metabolism and chronic renal insufficiency. Arch. Ital. Urol. Androl. 1994; 66 (1): 51-56.
- Di Mauro M., Papalia G., Le Moli R. et al. Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function. Diabetes Res. Clin. Pract. 2001; 51 (1): 45-50.
Supplementary files
